RU95115135A - Аналог долостатина - Google Patents

Аналог долостатина

Info

Publication number
RU95115135A
RU95115135A RU95115135/04A RU95115135A RU95115135A RU 95115135 A RU95115135 A RU 95115135A RU 95115135/04 A RU95115135/04 A RU 95115135/04A RU 95115135 A RU95115135 A RU 95115135A RU 95115135 A RU95115135 A RU 95115135A
Authority
RU
Russia
Prior art keywords
dolostatine
analog
peptides
effect
formulawhere
Prior art date
Application number
RU95115135/04A
Other languages
English (en)
Other versions
RU2132334C1 (ru
Inventor
Хаупт Андреас
De]
Янссен Бернд
Риттер Курт
Клинге Дагмар
Кейльхауер Герхард
Ромердаль Синтия
Барлоззари Тереза
Квиан Ксиао-Донг
Us]
Original Assignee
Басф Акциенгезелльшафт (De)
Басф Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Басф Акциенгезелльшафт (De), Басф Акциенгезелльшафт filed Critical Басф Акциенгезелльшафт (De)
Publication of RU95115135A publication Critical patent/RU95115135A/ru
Application granted granted Critical
Publication of RU2132334C1 publication Critical patent/RU2132334C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Window Of Vehicle (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Описаны новые пептиды формулы I,в которой значения R, R, X, А, R, В, D, E, R, M, Q, a, b и d указаны в описании, и способы их получения. Новые вещества обладают антинеопластическим действием.

Claims (1)

  1. Описаны новые пептиды формулы I,
    Figure 00000001

    в которой значения R1, R2, X, А, R3, В, D, E, R7, M, Q, a, b и d указаны в описании, и способы их получения. Новые вещества обладают антинеопластическим действием.
RU95115135A 1992-12-16 1993-12-04 Аналог долостатина RU2132334C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99130992A 1992-12-16 1992-12-16
US07/991309 1992-12-16
PCT/EP1993/003410 WO1994013695A1 (en) 1992-12-16 1993-12-04 Dolostatin analog

Publications (2)

Publication Number Publication Date
RU95115135A true RU95115135A (ru) 1997-06-10
RU2132334C1 RU2132334C1 (ru) 1999-06-27

Family

ID=25537082

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95115135A RU2132334C1 (ru) 1992-12-16 1993-12-04 Аналог долостатина

Country Status (24)

Country Link
US (1) US5502032A (ru)
EP (1) EP0674652B1 (ru)
JP (1) JPH08504415A (ru)
CN (1) CN1057095C (ru)
AT (1) ATE196296T1 (ru)
AU (1) AU679479B2 (ru)
BR (1) BR1100019A (ru)
CA (1) CA2151953A1 (ru)
CZ (1) CZ286752B6 (ru)
DE (1) DE69329425T2 (ru)
ES (1) ES2151921T3 (ru)
FI (1) FI952961A0 (ru)
HR (1) HRP931504B1 (ru)
HU (1) HUT72067A (ru)
IL (1) IL107987A (ru)
NO (1) NO952366D0 (ru)
NZ (1) NZ258882A (ru)
PL (1) PL178766B1 (ru)
RU (1) RU2132334C1 (ru)
SG (1) SG67935A1 (ru)
SI (1) SI9300661A (ru)
TW (1) TW400335B (ru)
WO (1) WO1994013695A1 (ru)
ZA (1) ZA939389B (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599902A (en) * 1994-11-10 1997-02-04 Arizona Board Of Regents Acting On Behalf Of Arizona State University Cancer inhibitory peptides
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
CA2360305A1 (en) 1999-02-09 2000-08-17 Bristol-Myers Squibb Company Lactam inhibitors of fxa and method
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
JP2004518688A (ja) 2001-01-30 2004-06-24 ブリストル−マイヤーズ　スクイブ　カンパニー ファクターＸａ阻害剤のスルホンアミドラクタムおよびその方法
EP1446110A2 (en) * 2001-10-16 2004-08-18 Structural Bioinformatics Inc. Organosulfur inhibitors of tyrosine phosphatases
AU2003218028A1 (en) 2002-03-08 2003-09-22 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
MXPA05012196A (es) * 2003-05-12 2006-02-08 Pfizer Prod Inc Compuestos de isoxazol e isotiazol para el tratamiento de trastornos neurodegenerativos.
US20060135773A1 (en) * 2004-06-17 2006-06-22 Semple Joseph E Trisubstituted nitrogen modulators of tyrosine phosphatases
WO2006017124A2 (en) * 2004-07-09 2006-02-16 Cengent Therapeutics, Inc. Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
EP1841749A1 (en) * 2004-09-02 2007-10-10 Metabasis Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
EP3498289A1 (en) 2005-07-07 2019-06-19 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus
WO2012171020A1 (en) 2011-06-10 2012-12-13 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
US10226535B2 (en) 2012-12-10 2019-03-12 Mersana Therapeutics, Inc. Auristatin compounds and conjugates thereof
CA2906784C (en) 2013-03-15 2023-02-28 The Centre For Drug Research And Development Cytotoxic and anti-mitotic compounds, and methods of using the same
WO2015095953A1 (en) 2013-12-27 2015-07-02 The Centre For Drug Research And Development Sulfonamide-containing linkage systems for drug conjugates
MX2016008448A (es) 2013-12-27 2017-01-09 Zymeworks Inc Conjugados de var2csa-farmaco.
KR102494557B1 (ko) 2014-09-17 2023-02-02 자임워크스 비씨 인코포레이티드 세포독성 및 항유사분열성 화합물, 그리고 이를 이용하는 방법
US10517958B2 (en) 2016-10-04 2019-12-31 Zymeworks Inc. Compositions and methods for the treatment of platinum-drug resistant cancer
CA3230737A1 (en) 2021-09-03 2023-03-09 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
EP0249008B1 (de) * 1986-05-09 1993-09-15 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore
JP2714402B2 (ja) * 1988-07-13 1998-02-16 日清製粉株式会社 癌転移抑制剤
EP0357332A3 (en) * 1988-08-24 1991-07-31 Merck & Co. Inc. Renin inhibitors useful for the treatment of aids by inhibition of hiv protease
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
US5138036A (en) * 1989-11-13 1992-08-11 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
DE69230824T2 (de) * 1991-08-09 2000-07-27 Teikoku Hormone Mfg Co Ltd Neue tetrapeptidderivate

Also Published As

Publication number Publication date
NZ258882A (en) 1997-06-24
FI952961A (fi) 1995-06-15
ES2151921T3 (es) 2001-01-16
EP0674652A1 (en) 1995-10-04
US5502032A (en) 1996-03-26
CZ157595A3 (en) 1996-01-17
SG67935A1 (en) 1999-10-19
CN1095724A (zh) 1994-11-30
NO952366L (no) 1995-06-15
PL178766B1 (pl) 2000-06-30
CZ286752B6 (en) 2000-06-14
TW400335B (en) 2000-08-01
FI952961A0 (fi) 1995-06-15
DE69329425D1 (de) 2000-10-19
HRP931504A2 (en) 1997-02-28
AU5695994A (en) 1994-07-04
CA2151953A1 (en) 1994-06-23
JPH08504415A (ja) 1996-05-14
ATE196296T1 (de) 2000-09-15
PL309353A1 (en) 1995-10-02
ZA939389B (en) 1995-06-15
IL107987A0 (en) 1994-04-12
HU9501754D0 (en) 1995-08-28
DE69329425T2 (de) 2001-01-18
RU2132334C1 (ru) 1999-06-27
BR1100019A (pt) 2000-07-25
HRP931504B1 (en) 2001-04-30
HUT72067A (en) 1996-03-28
CN1057095C (zh) 2000-10-04
EP0674652B1 (en) 2000-09-13
NO952366D0 (no) 1995-06-15
IL107987A (en) 1999-10-28
WO1994013695A1 (en) 1994-06-23
AU679479B2 (en) 1997-07-03
SI9300661A (en) 1994-06-30

Similar Documents

Publication Publication Date Title
RU95115135A (ru) Аналог долостатина
RU93033479A (ru) Способ получения замещенных пирролов, способ получения фармацевтических препаратов
RU93055882A (ru) Производные n-сульфонил-2-оксоиндола, способ их получения, исходные для их получения, фармацевтическая композиция на их основе
EP2202308A3 (en) Methods and compositions for polypeptide engineering
RU93048636A (ru) 7-/замещенные/-8-/замещенные/-9-/замещенные амино/-6-диметил-6-дезокситетрациклины, промежуточные соединения, способы получения соединений, способ профилактики и лечения и фармацевтическая композиция
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
RU93042100A (ru) Новые 7-(замещенные)-8-(замещенные)-9-[(замещенные глицил) амидо]-6-деметил-6-дезокситетрациклины
RU92004593A (ru) Производные гетероциклилметил-хромана в виде смеси изомеров или отдельных изомеров или их соли, способ их получения и лекарственное средство
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
DE69329304D1 (de) Enzymatische Verfahren zur Resolution von Enantiomeren-Mischungen nützlich wie Zwischenprodukte zur Herstellung von Taxanen
MY119042A (en) Dolastatin derivatives, their preparation and use
AU580973B2 (en) Novel polypeptides with an ``-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products
RU94046434A (ru) Новые пептиды, способ их получения и их применение
RU94027570A (ru) Способ получения замещенных пиперидинов, способ получения промежуточных продуктов, промежуточные продукты
DE69128473D1 (de) An sigma-bindungsstellen wirkende stoffe
RU93058546A (ru) Способ получения производных эрголина, фармацевтическая композиция
IT1230483B (it) Procedimento per la produzione di una proteina endotossica, gene strutturale impiegato e composizioni insetticide comprendenti detta proteina
NO174968C (no) Blanding anvendbar som kamuflasjematerial og maling inneholdende denne
BG92749A (bg) Производни на аминопропанола,метод за тяхното получаване и фармацетични състави,съдържащи тези производни
FI964446A0 (fi) Uusia tetrapeptidejä, niiden valmistus ja käyttö
RU94037761A (ru) Способ получения 3-ацилэстратриенов и ацилбензолов
DE3587252D1 (de) Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
RU92016589A (ru) Производные изоксазолилимидазола, способ их получения и их использование в лекарственных средствах
AU564040B2 (en) 1,2,3,4 - tetrahydro-1-aminomethyl-4-phenyl - isoquinolines
EP0457723A3 (de) Verfahren zum Stabilisieren von Magentakupplern und den entsprechenden Bildfarbstoffen in photographischen Materialien